Table 2 Operative and outcome data in both study groups
Variables | Ring group (n = 90) | Band group (n = 80) | p value |
|---|---|---|---|
Bypass time (min) | 116 ± 25.41 | 105.6 ± 20.33 | < 0.001* |
Cross clamp time (min) | 91 ± 28.6 | 76.7 ± 30.2 | < 0.001* |
Concomitant mitral valve surgery Repair | 6(6.7%) | 4(5%) | 0.64 |
Replacement | 84(93.3%) | 76(95%) | |
Types of ring or band | MC3 20: (22.2%) Contour 3D: 70 (77.8%) | Dacron: 70(87.5%) Gortex: 10(12.5%) | |
Postoperative mechanical ventilation (h) | 8.1 ± 1.9 | 7.7 ± 1 | 0.08 |
ICU stay (days) | 2.9 ± 0.76 | 2.6 ± 1.3 | 0.07 |
Hospital stay (days) | 7.4 ± 1.2 | 7.8 ± 1.5 | 0.06 |
Postoperative complications Reoperation for bleeding | 5(5.6%) | 3(3.8%) | 0.9 |
Renal failure | 2(2.2%) | 2(2.5%) | |
Cerebrovascular stroke | 1(1.1%) | 1(1.3%) | |
New pacemaker insertion | 1(1.1%) | 0(0%) | |
Tracheostomy | 0(0%) | 1(1.25%) | |
Pneumonia | 0(0%) | 2(2.5%) | |
In-hospital mortality | 1(1.1%) | 2(2.5%) | 0.49 |
Reoperation for recurrence | 0(0%) | 4(5%) | 0.001* |